• PDF: Delivered by email usually within 48 UK business hours.

Axcan Pharma Inc.
Strategic SWOT Analysis Review

  • Publication Date:May 2011
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:23

Axcan Pharma Inc. Strategic SWOT Analysis Review

Summary

Aptalis (formerly Axcan Pharma Inc.) is a privately held specialty pharmaceutical company engaged in development and commercialization of drugs for the treatment of gastrointestinal ailments and cystic fibrosis. It has more than 40 products and dosages in the market for the treatment of inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications related to pancreatic insufficiency. It also conducts research and development of advanced stage products acquired from third parties. It is involved in development and marketing of novel therapies and OTC drugs and marketed their products over 50 countries.The company has its operations in North America and Europe. The company is headquartered in Quebec, Canada.

Axcan Pharma Inc. Key Recent Developments

Mar 09, 2010: Axcan Pharma Selects Emtec For Value Based Management Services

GlobalData's Axcan Pharma Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - GlobalData's summarization of the company's business strategy.
  • SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
  • Section 1 - About the Company
    • Axcan Pharma Inc. - Key Facts
    • Axcan Pharma Inc. - Key Employees
    • Axcan Pharma Inc. - Key Employee Biographies
    • Axcan Pharma Inc. - Major Products and Services
    • Axcan Pharma Inc. - History
    • Axcan Pharma Inc. - Company Statement
    • Axcan Pharma Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
    • Axcan Pharma Inc. - Business Description
    • Axcan Pharma Inc. - SWOT Analysis
    • SWOT Analysis - Overview
    • Axcan Pharma Inc. - Strengths
    • Strength - Global Presence
    • Strength - Diversified Product Portfolio
    • Axcan Pharma Inc. - Weaknesses
    • Weakness - Limited No of Customers
    • Weakness - High Indebtedness
    • Weakness - Dependence on Third Party Manufacturers
    • Axcan Pharma Inc. - Opportunities
    • Opportunity - Emerging Markets
    • Opportunity - Product Pipeline
    • Opportunity - Changing Demographics
    • Axcan Pharma Inc. - Threats
    • Threat - Uncertain R&D Outcomes
    • Threat - Competitive Environment
    • Threat - Industry Consolidation
    • Axcan Pharma Inc. - Key Competitors
  • Section 3 - Company's Lifesciences Financial Deals and Alliances
    • Axcan Pharma Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
    • Axcan Pharma Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
    • Axcan Pharma Inc., Recent Deals Summary
  • Section 4 - Company's Recent Developments
    • Mar 09, 2010: Axcan Pharma Selects Emtec For Value Based Management Services
  • Section 5 - Appendix
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
  • List of Tables
    • Axcan Pharma Inc., Key Facts
    • Axcan Pharma Inc., Key Employees
    • Axcan Pharma Inc., Key Employee Biographies
    • Axcan Pharma Inc., Major Products and Services
    • Axcan Pharma Inc., History
    • Axcan Pharma Inc., Other Locations
    • Axcan Pharma Inc., Subsidiaries
    • Axcan Pharma Inc., Key Competitors
    • Axcan Pharma Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
    • Axcan Pharma Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
    • Axcan Pharma Inc., Recent Deals Summary
+44 20 8816 8548

Ask a question about Axcan Pharma Inc.

Enter the characters you see in the picture below
Captcha